Patents by Inventor Benoit Moreau

Benoit Moreau has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TARGETED CONJUGATES AND PARTICLES AND FORMULATIONS THEREOF
    Publication number: 20190125888
    Abstract: Nanoparticles and microparticles, and pharmaceutical formulations thereof, containing conjugates of an active agent such as maytansinoid attached to a targeting moiety, such as a somatostatin receptor binding moiety, via a linker have been designed. Such nanoparticles and microparticles can provide improved temporospatial delivery of the active agent and/or improved biodistribution. Methods of making the conjugates, the particles, and the formulations thereof are provided. Methods of administering the formulations to a subject in need thereof are provided.
    Type: Application
    Filed: June 27, 2016
    Publication date: May 2, 2019
    Inventors: Brian H. White, Mark T. Bilodeau, Benoît Moreau, Rajesh R. Shinde, Patrick Lim Soo, Beata Sweryda-Krawiec, Patrick Rosaire Bazinet, Rossitza G. Alargova, Craig A. Dunbar
  • A Method For Manufacturing A Martensitic Stainless Steel Part From A Sheet
    Publication number: 20190127829
    Abstract: A method for manufacturing a martensitic stainless steel part, according to which a stainless steel sheet is prepared with the following composition: 0.005%?C?0.3%; 0.2%?Mn?2.0%; traces?Si?1.0%; traces?S?0.01%; traces?P?0.04%; 10.5%?Cr?17.0%; traces?Ni?4.0%; traces?Mo?2.0%; Mo+2×W?2.0%; traces?Cu?3%; traces?Ti?0.5%; traces?Al?0.2%; traces?O?0.04%; 0.05%?Nb?1.0%; 0.05%?Nb+Ta?1.0%; 0.25%?(Nb+Ta)/(C+N)?8; traces?V?0.3%; traces?Co?0.5%; traces?Cu+Ni+Co?5.0%; traces?Sn?0.05%; traces?B?0.1%; traces?Zr?0.5%; Ti+V+Zr?0.5%; traces?H?5 ppm; traces?N?0.2%; (Mn+Ni)?(Cr-10.3-80×[(C+N)2]); traces?Ca?0.002%; traces?rare earth and/or Y?0.06%; and the rest being iron and impurities.
    Type: Application
    Filed: March 21, 2017
    Publication date: May 2, 2019
    Applicant: APERAM
    Inventors: Pierre-Olivier SANTACREU, Christophe CAZES, Guillaume BADINIER, Jean-Benoit MOREAU
  • COMPOUNDS, COMPOSITIONS, AND METHODS FOR THE TREATMENT OF CANCERS
    Publication number: 20190015378
    Abstract: The present teachings relate to compounds and compositions for treatment of cancers. In some embodiments, the composition comprises a platinum (IV) complex having at least one carboxylate or carbamate ligand.
    Type: Application
    Filed: September 19, 2018
    Publication date: January 17, 2019
    Inventors: Mark T. Bilodeau, Craig A. Dunbar, Timothy E. Barder, Edward R. Lee, Rossitza G. Alargova, Danielle N. Rockwood, Rajesh R. Shinde, Patrick Lim Soo, Benoît Moreau
  • Compounds, compositions, and methods for the treatment of cancers
    Patent number: 10111853
    Abstract: The present teachings relate to compounds and compositions for treatment of cancers. In some embodiments, the composition comprises a platinum (IV) complex having at least one carboxylate or carbamate ligand.
    Type: Grant
    Filed: December 13, 2016
    Date of Patent: October 30, 2018
    Assignee: PLACON THERAPEUTICS, INC.
    Inventors: Mark T. Bilodeau, Craig A. Dunbar, Timothy E. Barder, Edward R. Lee, Rossitza G. Alargova, Danielle N. Rockwood, Rajesh Shinde, Patrick Lim Soo, Benoît Moreau
  • COMPOUNDS, COMPOSITIONS, AND METHODS FOR THE TREATMENT OF CANCERS
    Publication number: 20180273567
    Abstract: The present teachings relate to compounds and compositions for treatment of cancers. In some embodiments, the composition comprises a platinum (IV) complex having at least one carboxylate or carbamate ligand.
    Type: Application
    Filed: May 31, 2018
    Publication date: September 27, 2018
    Inventors: Mark T. Bilodeau, Benoît Moreau, Adam H. Brockman
  • PLATINUM COMPOUNDS, COMPOSITIONS, AND USES THEREOF
    Publication number: 20180243318
    Abstract: The present teachings relate to compounds and compositions for treatment of cancers. In some embodiments, the composition comprises a platinum (IV) complex having at least one reacting group for reacting with a functional group on a protein.
    Type: Application
    Filed: June 22, 2016
    Publication date: August 30, 2018
    Inventors: Rossitza G. Alargova, Mark T. Bilodeau, Richard Wooster, Benoît Moreau, Kerry Whalen, J. Michael Ramstack, Danielle N. Rockwood, Patrick Lim Soo, Sukhjeet Singh, Tsun P. Au Yeung, Charles-Andre Lemelin, Linda M. Custer
  • PLATINUM COMPOUNDS, COMPOSITIONS, AND USES THEREOF
    Publication number: 20180186823
    Abstract: The present teachings relate to compounds and compositions comprising a platinum (IV) complex having at least one reacting group for reacting with a functional group on a protein, engineered protein, antibody, antibody fragment, peptide, agonist, antagonist, aptamer or any moiety which may be capable of recognizing a selected target cell population, and/or derivatives/analogs/mimics thereof. The platinum (IV) complex may comprise at least one active agent.
    Type: Application
    Filed: June 22, 2016
    Publication date: July 5, 2018
    Inventors: Sudhakar Kadiyala, Benoît Moreau, Mark T. Bilodeau, Kerry Whalen, Sukhjeet Singh, Richard Wooster, Charles-Andre Lemelin
  • Compounds, compositions, and methods for the treatment of cancers
    Patent number: 10011622
    Abstract: The present teachings relate to compounds and compositions for treatment of cancers. In some embodiments, the composition comprises a platinum (IV) complex having at least one carboxylate or carbamate ligand.
    Type: Grant
    Filed: December 18, 2014
    Date of Patent: July 3, 2018
    Assignee: PLACON THERAPEUTICS, INC.
    Inventors: Mark T. Bilodeau, Benoît Moreau, Adam H. Brockman
  • Platinum compounds, compositions, and uses thereof
    Patent number: 9937187
    Abstract: The present teachings relate to compounds and compositions for treatment of cancers. In some embodiments, the composition comprises a platinum (IV) complex having at least one reacting group for reacting with a functional group on a protein, engineered protein, antibody, antibody fragment, peptide, agonist, antagonist, aptamer or ligand which may be capable of recognizing a selected target cell population, and/or derivatives/analogs/mimics thereof.
    Type: Grant
    Filed: June 10, 2016
    Date of Patent: April 10, 2018
    Assignee: PLACON THERAPEUTICS, INC.
    Inventors: Mark T. Bilodeau, Benoît Moreau, Adam H. Brockman, Kristan Meetze, Kerry Whalen, Richard Wooster, Rossitza G. Alargova
  • TARGETED CONJUGATES ENCAPSULATED IN PARTICLES AND FORMULATIONS THEREOF
    Publication number: 20180021454
    Abstract: Particles, including nanoparticles and microparticles, and pharmaceutical formulations thereof, containing conjugates of an active agent such as a therapeutic, prophylactic, or diagnostic agent attached to a targeting moiety via a linker have been designed which can provide improved temporospatial delivery of the active agent and/or improved biodistribution. Methods of making the conjugates, the particles, and the formulations thereof are provided. Methods of administering the formulations to a subject in need thereof are provided, for example, to treat or prevent cancer or infectious diseases.
    Type: Application
    Filed: September 5, 2017
    Publication date: January 25, 2018
    Inventors: Mark T. Bilodeau, Sudhakar Kadiyala, Rajesh R. Shinde, Brian H. White, Richard Wooster, Benoît Moreau
  • PLATINUM COMPOUNDS, COMPOSITIONS, AND USES THEREOF
    Publication number: 20180008614
    Abstract: The present teachings relate to compounds and compositions for treatment of cancers. In some embodiments, the composition comprises a platinum (IV) complex having at least one reacting group for reacting with a functional group on a protein, engineered protein, antibody, antibody fragment, peptide, agonist, antagonist, aptamer or ligand which may be capable of recognizing a selected target cell population, and/or derivatives/analogs/mimics thereof.
    Type: Application
    Filed: September 21, 2017
    Publication date: January 11, 2018
    Inventors: Mark T. Bilodeau, Benoît Moreau, Adam H. Brockman, Kristan Meetze, Kerry Whalen, Richard Wooster, Rossitza G. Alargova
  • PLATINUM COMPOUNDS HAVING A HETEROCYCLE LIGAND, NANOPARTICLES, AND USES THEREOF
    Publication number: 20170349615
    Abstract: The present disclosure relates to novel platinum compositions having a heterocycle ligand and nanoparticles and methods using such compositions, e.g. for treating cancer.
    Type: Application
    Filed: August 24, 2017
    Publication date: December 7, 2017
    Inventors: Adam H. Brockman, Mark T. Bilodeau, Benoît Moreau, Edward R. Lee
  • COMPOUNDS, COMPOSITIONS, AND METHODS FOR THE TREATMENT OF CANCERS
    Publication number: 20170313733
    Abstract: The present teachings relate to compounds and compositions for treatment of cancers. In some embodiments, the composition comprises a platinum (IV) complex having at least one polar moiety as a ligand.
    Type: Application
    Filed: July 18, 2017
    Publication date: November 2, 2017
    Inventors: Mark T. Bilodeau, Benoît Moreau
  • Platinum compounds having a heterocycle ligand, nanoparticles, and uses thereof
    Patent number: 9771387
    Abstract: The present disclosure relates to novel platinum compositions having a heterocycle ligand and nanoparticles and methods using such compositions, e.g. for treating cancer.
    Type: Grant
    Filed: July 16, 2014
    Date of Patent: September 26, 2017
    Assignee: PLACON THERAPEUTICS
    Inventors: Adam H. Brockman, Mark T. Bilodeau, Benoît Moreau, Edward R. Lee
  • Compounds, compositions, and methods for the treatment of cancers
    Patent number: 9738672
    Abstract: The present teachings relate to compounds and compositions for treatment of cancers. In some embodiments, the composition comprises a platinum (IV) complex having at least one polar moiety as a ligand.
    Type: Grant
    Filed: December 18, 2014
    Date of Patent: August 22, 2017
    Assignee: PLACON THERAPEUTICS, INC.
    Inventors: Mark T. Bilodeau, Benoît Moreau
  • COMPOUNDS, COMPOSITIONS, AND METHODS FOR THE TREATMENT OF CANCERS
    Publication number: 20170087118
    Abstract: The present teachings relate to compounds and compositions for treatment of cancers. In some embodiments, the composition comprises a platinum (IV) complex having at least one carboxylate or carbamate ligand.
    Type: Application
    Filed: December 13, 2016
    Publication date: March 30, 2017
    Inventors: Mark T. Bilodeau, Craig A. Dunbar, Timothy E. Barder, Edward R. Lee, Rossitza G. Alargova, Danielle N. Rockwood, Rajesh Shinde, Patrick Lim Soo, Benoît Moreau
  • Compounds, compositions, and methods for the treatment of cancers
    Patent number: 9556214
    Abstract: The present teachings relate to compounds and compositions for treatment of cancers. In some embodiments, the composition comprises a platinum (IV) complex having at least one carboxylate or carbamate ligand.
    Type: Grant
    Filed: December 19, 2013
    Date of Patent: January 31, 2017
    Assignee: PLACON THERAPEUTICS, INC.
    Inventors: Mark T. Bilodeau, Craig A. Dunbar, Timothy E. Barder, Edward R. Lee, Rossitza G. Alargova, Danille N. Rockwood, Rajesh Shinde, Patrick Lim Soo, Benoît Moreau
  • Inhibitors of cytomegalovirus
    Patent number: 9505775
    Abstract: Compounds of Formula (I) wherein R1, R2, R3A, R3B, Y, Z1 and Z2 are defined herein, are useful for the treatment of cytomegalovirus disease and/or infection.
    Type: Grant
    Filed: October 31, 2013
    Date of Patent: November 29, 2016
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Carl Thibeault, Jean Rancourt, Pierre L. Beaulieu, Anne Décor, Chantal Grand-Maitre, Cyrille Kuhn, Elisia Villemure, Oliver Hucke, Simon Surprenant, Melissa Leblanc, Jean-Eric Lacoste, Benoit Moreau, Eric Jolicoeur
  • COMPOUNDS, COMPOSITIONS, AND METHODS FOR THE TREATMENT OF CANCERS
    Publication number: 20160326201
    Abstract: The present teachings relate to compounds and compositions for treatment of cancers. In some embodiments, the composition comprises a platinum (IV) complex having at least one carboxylate or carbamate ligand.
    Type: Application
    Filed: December 18, 2014
    Publication date: November 10, 2016
    Inventors: Mark T. Bilodeau, Benoît Moreau, Adam H. Brockman
  • PLATINUM COMPOUNDS, COMPOSITIONS, AND USES THEREOF
    Publication number: 20160317549
    Abstract: The present teachings relate to compounds and compositions for treatment of cancers. In some embodiments, the composition comprises a platinum (IV) complex having at least one reacting group for reacting with a functional group on a protein, engineered protein, antibody, antibody fragment, peptide, agonist, antagonist, aptamer or ligand which may be capable of recognizing a selected target cell population, and/or derivatives/analogs/mimics thereof.
    Type: Application
    Filed: June 10, 2016
    Publication date: November 3, 2016
    Inventors: Mark T. Bilodeau, Benoît Moreau, Adam H. Brockman